Compare NEGG & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEGG | ARAY |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | United States |
| Employees | N/A | 990 |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 100.5M |
| IPO Year | 2010 | 2007 |
| Metric | NEGG | ARAY |
|---|---|---|
| Price | $53.10 | $0.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 111.4K | ★ 1.3M |
| Earning Date | 04-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,313,127,000.00 | $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $3.32 | $0.78 |
| 52 Week High | $137.84 | $2.95 |
| Indicator | NEGG | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 41.76 |
| Support Level | $50.00 | $0.78 |
| Resistance Level | $53.57 | $0.94 |
| Average True Range (ATR) | 3.93 | 0.05 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 26.92 | 41.71 |
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.